1	Effects	Effect	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	glucocorticoids	glucocorticoid	_	_	_	_	_	_	_
4	on	on	_	_	_	_	_	_	_
5	transcription	transcription	_	_	_	_	_	_	_
6	factor	factor	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	peripheral	peripheral	_	_	_	_	_	_	_
11	blood	blood	_	_	_	_	_	_	_
12	mononuclear	mononuclear	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Glucocorticoids	glucocorticoid	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	an	an	_	_	_	_	_	_	_
4	inhibitory	inhibitory	_	_	_	_	_	_	_
5	effect	effect	_	_	_	_	_	_	_
6	on	on	_	_	_	_	_	_	_
7	inflammatory	inflammatory	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	immune	immune	_	_	_	_	_	_	_
10	responses	response	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	this	this	_	_	_	_	_	_	_
14	may	may	_	_	_	_	_	_	_
15	be	be	_	_	_	_	_	_	_
16	through	through	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	modulation	modulation	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	transcription	transcription	_	_	_	_	_	_	_
21	factor	factor	_	_	_	_	_	_	_
22	binding	bind	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	DNA	DNA	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	interaction	interaction	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	transcription	transcription	_	_	_	_	_	_	_
6	factors	factor	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	activator	activator	_	_	_	_	_	_	_
9	protein-1	protein-1	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	AP-1	ap-1	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	nuclear	nuclear	_	_	_	_	_	_	_
15	factor	factor	_	_	_	_	_	_	_
16	kappa	kappa	_	_	_	_	_	_	_
17	B	B	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	NF	NF	_	_	_	_	_	_	_
20	kappa	kappa	_	_	_	_	_	_	_
21	B	B	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	cAMP-responsive	camp-responsive	_	_	_	_	_	_	_
26	element	element	_	_	_	_	_	_	_
27	binding	binding	_	_	_	_	_	_	_
28	protein	protein	_	_	_	_	_	_	_
29	(	(	_	_	_	_	_	_	_
30	CREB	CREB	_	_	_	_	_	_	_
31	)	)	_	_	_	_	_	_	_
32	with	with	_	_	_	_	_	_	_
33	DNA	DNA	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
36	receptors	receptor	_	_	_	_	_	_	_
37	(	(	_	_	_	_	_	_	_
38	GR	GR	_	_	_	_	_	_	_
39	)	)	_	_	_	_	_	_	_
40	was	be	_	_	_	_	_	_	_
41	analyzed	analyze	_	_	_	_	_	_	_
42	in	in	_	_	_	_	_	_	_
43	human	human	_	_	_	_	_	_	_
44	peripheral	peripheral	_	_	_	_	_	_	_
45	blood	blood	_	_	_	_	_	_	_
46	mononuclear	mononuclear	_	_	_	_	_	_	_
47	cells	cell	_	_	_	_	_	_	_
48	by	by	_	_	_	_	_	_	_
49	gel	gel	_	_	_	_	_	_	_
50	mobility	mobility	_	_	_	_	_	_	_
51	shift	shift	_	_	_	_	_	_	_
52	assays	assay	_	_	_	_	_	_	_
53	.	.	_	_	_	_	_	_	_

1	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	IL-1	il-1	_	_	_	_	_	_	_
4	beta	beta	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	phorbol	phorbol	_	_	_	_	_	_	_
7	myristate	myristate	_	_	_	_	_	_	_
8	acetate	acetate	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	PMA	PMA	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	treatment	treatment	_	_	_	_	_	_	_
13	increased	increase	_	_	_	_	_	_	_
14	AP-1	ap-1	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	NF	NF	_	_	_	_	_	_	_
17	kappa	kappa	_	_	_	_	_	_	_
18	B	B	_	_	_	_	_	_	_
19	DNA	DNA	_	_	_	_	_	_	_
20	binding	binding	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	up	up	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	200	200	_	_	_	_	_	_	_
25	%	%	_	_	_	_	_	_	_
26	but	but	_	_	_	_	_	_	_
27	decreased	decrease	_	_	_	_	_	_	_
28	CREB	CREB	_	_	_	_	_	_	_
29	binding	binding	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	38	38	_	_	_	_	_	_	_
32	%	%	_	_	_	_	_	_	_
33	)	)	_	_	_	_	_	_	_
34	over	over	_	_	_	_	_	_	_
35	a	a	_	_	_	_	_	_	_
36	60-min	60-min	_	_	_	_	_	_	_
37	time	time	_	_	_	_	_	_	_
38	course	course	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	Dexamethasone	Dexamethasone	_	_	_	_	_	_	_
2	produced	produce	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	rapid	rapid	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	sustained	sustained	_	_	_	_	_	_	_
7	increase	increase	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
10	response	response	_	_	_	_	_	_	_
11	element	element	_	_	_	_	_	_	_
12	binding	binding	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	concomitant	concomitant	_	_	_	_	_	_	_
16	40-50	40-50	_	_	_	_	_	_	_
17	%	%	_	_	_	_	_	_	_
18	decrease	decrease	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	AP-1	ap-1	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	NF	NF	_	_	_	_	_	_	_
23	kappa	kappa	_	_	_	_	_	_	_
24	B	B	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	CREB	CREB	_	_	_	_	_	_	_
28	DNA	DNA	_	_	_	_	_	_	_
29	binding	binding	_	_	_	_	_	_	_
30	that	that	_	_	_	_	_	_	_
31	was	be	_	_	_	_	_	_	_
32	blocked	block	_	_	_	_	_	_	_
33	by	by	_	_	_	_	_	_	_
34	combined	combined	_	_	_	_	_	_	_
35	dexamethasone	dexamethasone	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	cytokine	cytokine	_	_	_	_	_	_	_
38	or	or	_	_	_	_	_	_	_
39	PMA	PMA	_	_	_	_	_	_	_
40	treatment	treatment	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	latter	latter	_	_	_	_	_	_	_
3	effects	effect	_	_	_	_	_	_	_
4	were	be	_	_	_	_	_	_	_
5	due	due	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	increases	increase	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	nuclear	nuclear	_	_	_	_	_	_	_
11	localization	localization	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	GR	GR	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	not	not	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	reduced	reduce	_	_	_	_	_	_	_
18	amounts	amount	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	other	other	_	_	_	_	_	_	_
22	transcription	transcription	_	_	_	_	_	_	_
23	factors	factor	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	suggests	suggest	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	these	these	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	GR	gr	_	_	_	_	_	_	_
8	within	within	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	nucleus	nucleus	_	_	_	_	_	_	_
11	interacts	interact	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	cytokine-stimulated	cytokine-stimulated	_	_	_	_	_	_	_
14	transcription	transcription	_	_	_	_	_	_	_
15	factors	factor	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	process	process	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	cross	cross	_	_	_	_	_	_	_
21	coupling	coupling	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	may	may	_	_	_	_	_	_	_
3	be	be	_	_	_	_	_	_	_
4	an	an	_	_	_	_	_	_	_
5	important	important	_	_	_	_	_	_	_
6	molecular	molecular	_	_	_	_	_	_	_
7	site	site	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	steroid	steroid	_	_	_	_	_	_	_
10	action	action	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

